Oral MS drug Cladribine 'Shuts Down MS Activity'

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Oral MS drug Cladribine 'Shuts Down MS Activity'

Post by MSUK » Wed Jun 09, 2010 2:53 am

Image

Cladribine, an oral drug already marketed for hematologic cancers under the trade name Leustatin, was superior to placebo in reducing progression and other signs of MS disease activity, researchers reported at CMSC-ACTRIMS.

Freedom from any disease activity, including relapse, disability progression, or MRI progression, was experienced by 44.3% of patients treated with a high-dose of cladribine, and 43% of patients randomized to a low-dose regimen compared with 16% of placebo patients (P<0.001), said Gavin Giovannoni, PhD, from the Blizard Institute of Cell and Molecular Science at the Barts and the London School of Medicine and Dentistry in London, England.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1629
MS-UK - http://www.ms-uk.org/

LR1234
Family Elder
Posts: 1517
Joined: Wed Feb 11, 2009 3:00 pm
Location: California
Contact:

Post by LR1234 » Wed Jun 09, 2010 3:19 am

I just don't know whether to believe them or not:(

Its so terrible not to be able to trust your dr's and the scientists but years of bad experiences with the medical establishment as led me to question everything they say (and do).

I really do hope it works and that the side effects are not too severe like PML or death!

User avatar
viper498
Family Elder
Posts: 428
Joined: Sun Oct 09, 2005 2:00 pm
Location: Missouri, USA
Contact:

Post by viper498 » Thu Jun 10, 2010 4:57 am

Agreed. They could be feeding the media, or lying about the numbers. Who knows? I can't help being cynical myself.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post